Aims: To investigate CT-derived extracellular volume fraction (CT-ECV) in patients with lone aortic stenosis (AS), dual pathology of AS and transthyretin cardiac amyloidosis (AS-ATTR), and lone ATTR, and to examine the diagnostic performance and optimal cutoff values of CT-ECV for differentiating between patients with lone AS and AS-ATTR, and between patients with lone AS and lone ATTR.
Methods and results: This retrospective study included consecutive patients with severe AS (including lone AS and AS-ATTR) and lone ATTR who underwent CT-ECV analysis and technetium 99m pyrophosphate (99mTc-PYP) scintigraphy. The diagnostic performance of CT-ECV for detecting cardiac amyloidosis was evaluated using the area under the receiver operating characteristic curve (AUC). Of 138 patients (mean age, 80 ± 8; 96 men), 55 had lone AS, 19 had AS-ATTR and 64 had lone ATTR. CT-ECV of patients with lone AS was 31 ± 5%. CT-ECV was significantly lower in patients with AS-ATTR than lone ATTR (45 ± 12% vs 53 ± 13%, P =.04). The AUC for differentiating patients with AS-ATTR from lone AS was lower than for lone ATTR from lone AS (0.90 [95% CI: 0.81, 0.96] vs 0.95 [95% CI: 0.90, 0.98]). The cutoff values of CT-ECV for differentiation between patients with lone AS and AS-ATTR were lower than those between patients with lone AS and lone ATTR (36.6% vs 38.5% [Youden index]). There was no significant difference in the proportion of 99mTc-PYP scintigraphy grade between patients with AS-ATTR and lone-ATTR (P = .20).
Conclusion: Despite no significant difference in degree of ATTR between patients with AS-ATTR and lone ATTR, CT-ECV of patients with dual AS-ATTR pathology was significantly lower than that of patients with lone ATTR. The diagnostic performance and optimal cutoff values of CT-ECV for differentiating between patients with lone AS and AS-ATTR were lower than those between patients with lone AS and lone ATTR.
Keywords: aortic stenosis; cardiac CT; cardiac amyloidosis; extracellular volume fraction.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].